Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Flow Cytometry01:23

Flow Cytometry

The development of flow cytometry techniques began in 1934 with initial attempts by Andrew Moldavan, a bacteriologist who counted the cells in a flowing capillary system. Moldavan pumped cells through a capillary tube focused under a microscope for visualization. The invention of photometry allowed the measurement of differentially-stained cells, and Louis Kamentsky developed the first multiparameter flow cytometer in 1965 to identify and count the cancer cells in cervical tissue specimens.
In...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2018 Conference Workshops.

Cytometry. Part A : the journal of the International Society for Analytical Cytology·2019
See all related articles

Related Experiment Video

Updated: May 16, 2026

Preparation of Whole Bone Marrow for Mass Cytometry Analysis of Neutrophil-lineage Cells
08:09

Preparation of Whole Bone Marrow for Mass Cytometry Analysis of Neutrophil-lineage Cells

Published on: June 19, 2019

Flow cytometry: a flexible tool for biomarker research.

Ruth M Barnard1

  • 1Translational Medicine, Biopharm R&D, GlaxoSmithKline, Stevenage, Hertfordshire, SG1 2NY, UK. ruth.m.barnard@gsk.com

Bioanalysis
|November 20, 2012
PubMed
Summary

Flow cytometry is a powerful tool for biomarker research, offering detailed single-cell analysis. Standardization and advanced software are needed to fully leverage its potential in clinical and preclinical settings.

Area of Science:

  • Biomedical Sciences
  • Cell Biology
  • Immunology

Background:

  • Flow cytometry is a key technology for analyzing heterogeneous cell populations.
  • Its multiparametric capabilities provide in-depth single-cell information.
  • The technology is applicable in both preclinical research and clinical diagnostics.

Purpose of the Study:

  • To highlight the significance of flow cytometry in biomarker research.
  • To discuss the applications of flow cytometry in clinical trials and patient care.
  • To identify areas for improvement in flow cytometry assays and data analysis.

Main Methods:

  • Multiparametric flow cytometry is utilized for detailed cellular analysis.
  • Data generated spans preclinical and clinical research settings.

More Related Videos

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
10:58

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

Published on: March 5, 2019

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

Related Experiment Videos

Last Updated: May 16, 2026

Preparation of Whole Bone Marrow for Mass Cytometry Analysis of Neutrophil-lineage Cells
08:09

Preparation of Whole Bone Marrow for Mass Cytometry Analysis of Neutrophil-lineage Cells

Published on: June 19, 2019

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry
10:58

Discrimination of Seven Immune Cell Subsets by Two-fluorochrome Flow Cytometry

Published on: March 5, 2019

Quality-Controlled Sputum Analysis by Flow Cytometry
07:22

Quality-Controlled Sputum Analysis by Flow Cytometry

Published on: August 9, 2021

  • Various tissue types are compatible with flow cytometry.
  • Main Results:

    • Flow cytometry provides crucial biomarker data for clinical decision-making.
    • It aids in dose selection for clinical trials and cancer treatment strategies.
    • The technology assists in determining patient suitability for transplants.

    Conclusions:

    • Flow cytometry is essential for both routine and exploratory biomarker studies.
    • Further standardization, regulation, and validation of multiparametric assays are required.
    • Continuous innovation in analysis software is necessary to manage large datasets.